Pharmaceuticals - Jacksonville, Florida, United States
Progen Pharmaceuticals Limited (ASX:PGL, OTC:PGLA) is a globally focused biotechnology company committed to improving patient outcomes through the discovery and development of small molecule-based cancer therapeutics. Progen's core focus is development of the anti-angiogenesis and anti-metastatic oncology products pipeline. The dual mechanism therapeutic approach focuses on both controlling tumour growth and spread.